Longboard Pharmaceuticals, Inc. (LBPH)
Dec 2, 2024 - LBPH was delisted (reason: acquired by Lundbeck)
59.98
0.00 (0.00%)
Inactive · Last trade price on Nov 29, 2024

Longboard Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
2,3421445682-
Market Cap Growth
818.07%156.33%-31.82%--
Enterprise Value
2,05788-20-30-
Last Close Price
33.336.033.264.88-
PB Ratio
8.513.520.910.80-
P/TBV Ratio
4.713.520.910.80-
Debt / Equity Ratio
0.010.010.010.01-
Quick Ratio
15.724.967.7119.6017.64
Current Ratio
15.975.147.9719.9117.66
Return on Equity (ROE)
-46.66%-106.30%-53.33%-35.54%-
Return on Assets (ROA)
-30.72%-58.48%-31.18%-21.07%-
Return on Capital (ROIC)
-32.98%-68.48%-33.72%-22.17%-
Earnings Yield
-3.26%-37.83%-78.30%-33.77%-
FCF Yield
-2.82%-35.36%-67.82%-30.03%-
Buyback Yield / Dilution
-63.09%-32.51%-19.02%-278.34%-
Total Shareholder Return
-63.09%-32.51%-19.02%-278.34%-
Source: S&P Capital IQ. Standard template. Financial Sources.